Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2001
05/31/2001DE19957638A1 Detecting antibiotics uses thin layer chromatography, a DC plate and bacterial cultures
05/31/2001DE19957493A1 Determining the identity of C13-urea for the administration of certain medicines, comprises using infra-red spectroscopy at a specific wavelength
05/31/2001DE19957319A1 Detecting analytes in a sample uses determination cycles using immobilized receptors
05/31/2001DE19956943A1 Vorrichtung zur Kontrolle der Verdichtung bei Vibrationsverdichtungsgeräten Device for controlling the compression in vibratory compaction equipment
05/31/2001DE19956820A1 Spezies-spezifischer Nachweis von Nukleinsäuren mittels eines Analyseelementes Species-specific detection of nucleic acids by means of an analysis element
05/31/2001DE19952509A1 Polyclonal antiserum against human leucocyte antigen-G, useful for predicting success of in vitro fertilization and for prognosis of melanoma
05/31/2001DE19949922C1 Verfahren und Vorrichtung zum Messen der Schaumeigenschaften von Flüssigkeiten Method and apparatus for measuring the foam properties of liquids
05/31/2001DE19924906C2 Halbleiter-Gassensor, Gassensorsystem und Verfahren zur Gasanalyse Semiconductor gas sensor, the gas sensor system and method for gas analysis
05/31/2001DE10056131A1 Mineral oil laboratory sample test unit has chilling section with Stirling circuit or propellant gas and heat transfer element with dry contacts
05/31/2001CA2422429A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
05/31/2001CA2395353A1 Continuous time-resolved resonance energy-transfer assay for polynucleic acid polymerases
05/31/2001CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
05/31/2001CA2392649A1 Assay of isomerised and/or optically inverted proteins
05/31/2001CA2392639A1 G-protein coupled receptor htogh35
05/31/2001CA2392495A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
05/31/2001CA2392491A1 Method of detecting gynecological carcinomas
05/31/2001CA2392474A1 Nucleic acid probe arrays
05/31/2001CA2392469A1 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample
05/31/2001CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
05/31/2001CA2392351A1 Novel transcription factor and dna thereof
05/31/2001CA2392217A1 Methods of inhibiting atrophy or promoting hypertrophy
05/31/2001CA2392015A1 Method of separating prions from biological materials
05/31/2001CA2392001A1 Standard sample composition and manufacture thereof
05/31/2001CA2391499A1 Compositions and methods for treatment of allergic disorders
05/31/2001CA2390599A1 Prognostic testing of organs intended for transplantation
05/31/2001CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
05/31/2001CA2388825A1 Multiblot kinase analysis
05/31/2001CA2363092A1 Method and machine for grading timber elements
05/31/2001CA2360750A1 Capillary array-based sample screening
05/30/2001EP1103911A1 Automated method for identifying related biomolecular sequences
05/30/2001EP1103814A1 Method for assaying physiologically active component
05/30/2001EP1103808A2 Gas sensor and method for its manufacturing
05/30/2001EP1103807A2 Hydrogen gas sensor
05/30/2001EP1103769A1 Refrigerating device for gases of analysis
05/30/2001EP1103658A2 Device for controlling the compaction effect of vibrating devices
05/30/2001EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods
05/30/2001EP1103622A2 Species specific detection of nucleic acids using an analysing element
05/30/2001EP1103562A1 Novel g-protein coupled receptor protein and dna thereof
05/30/2001EP1103304A2 Self-venting reagent vessel and method of delivering a reagent to an analyzing instrument or other apparatus
05/30/2001EP1102994A2 Automated immunoassay apparatus with flexible pick-up arm
05/30/2001EP1102993A1 Method for detecting drugs, and a solvent and a decomposition solution therefor
05/30/2001EP1102992A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease
05/30/2001EP1102991A2 Diagnostic assay requiring a small sample of biological fluid
05/30/2001EP1102990A1 Sample analysis
05/30/2001EP1102989A2 Analytical test device and method
05/30/2001EP1102988A2 Method for determining the immune defences of blood, test kit therefor and use of a suitable system for taking blood samples
05/30/2001EP1102987A1 Method and apparatus for monitoring water balance in a papermachine
05/30/2001EP1102981A1 Gas sensor comprising a shield grid electrode for minimizing leakage current influences, and the use thereof
05/30/2001EP1102977A1 Fluorescence assay for biological systems
05/30/2001EP1102976A1 Multiple frequency fluorescence lifetime imaging
05/30/2001EP1102974A1 Device and method for determining the hemoglobin value in blood
05/30/2001EP1102865A2 Methods and compositions for modulating "marginally indiscriminant" hybridizations
05/30/2001EP1102864A1 Gel microdrops in genetic analysis
05/30/2001EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene
05/30/2001EP1102861A1 Modelling organic compound reactivity in cytochrome p450 mediated reactions
05/30/2001EP1102853A1 N-acetylglycosaminyltransferase genes
05/30/2001EP1102850A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization
05/30/2001EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto
05/30/2001EP1102847A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents
05/30/2001EP1102846A1 Pancreatic and ovarian polypeptide, zsig58
05/30/2001EP1102844A2 Human neuronal acid-sensitive cationic channel, its cloning and applications
05/30/2001EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
05/30/2001EP1102828A1 A process for producing a lubricant base oil having improved oxidative stability
05/30/2001EP1102791A1 Modified green fluorescent protein
05/30/2001EP1102788A2 Prevention and treatment of viral disease
05/30/2001EP1102641A1 Method and device for optimising lacquers
05/30/2001EP1102623A2 Template-textured materials, methods for the production and use thereof
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001EP1102564A1 Method and apparatus for respiratory gas analysis employing measurement of expired gas mass
05/30/2001EP1102561A1 Press device for a gel/sensor assembly
05/30/2001EP1102559A1 Method and device for predicting physiological values
05/30/2001EP1057022A4 Assay for specific strains of multiple disease related conformations of a protein
05/30/2001EP1023604A4 Method for localization and quantitation of a substance in a biological sample
05/30/2001EP0965032A4 Capacitive oil deterioration and contamination sensor
05/30/2001EP0937252B1 Method of establishing the origin of useful animals and products produced therefrom
05/30/2001EP0883699B1 Method and devices for the electrolytic formation of a deposit on an assembly of selected electrodes
05/30/2001EP0870197B1 Use of nuclear magnetic resonance to design ligands to target biomolecules
05/30/2001EP0799420B1 Haptene assay by a competition-based method
05/30/2001EP0721586B1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders
05/30/2001EP0620822B1 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
05/30/2001CN2432587Y Biological safety working table with high temp. sterilizing device
05/30/2001CN2432586Y Microscope for observing schistosomulum
05/30/2001CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents
05/30/2001CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof
05/30/2001CN1297529A Automated molecular pathology apparatus having independent slide heaters
05/30/2001CN1297489A Method and apparatus for determination of length polymorphisms in DNA
05/30/2001CN1297488A Method for detection of target nucleic acids using PCR
05/30/2001CN1297484A Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
05/30/2001CN1297380A Continuous magnetic separation of components from mixture
05/30/2001CN1297153A Process for detecting components in Chinese medicine with specific antibodies
05/30/2001CN1297148A Method for measuring ozone treated level for liquid to be treated
05/30/2001CN1297058A Detection of variation of nucleotide sequence by moving termination analysis
05/30/2001CN1296976A Polypeptide-human epidermal growth factor receptor protein 25 and polynucleotide for coding said polypeptide
05/30/2001CN1296972A Polypeptide-human myosin heavy chain 74 and polynucleotide for coding said polypeptide
05/30/2001CN1296971A Polypeptide-huntingtin protein interactive protein 65 and polynucleotide for coding said polypeptide
05/30/2001CN1296969A Polypeptide-human X chromosome linked gene expression protein 14 and polynucleotide for coding said polypeptide
05/30/2001CN1296965A Polypeptide-human fibrous growth factor receptor 46 and polynucleotide for coding said polypeptide
05/30/2001CN1296963A Polypeptide-human vascular epithelium cadherin 54 and polynucleotide for coding said polypeptide
05/30/2001CN1296961A Polypeptide-human CDC4 analogous protein 13 and polynucleotide for coding said polypeptide
05/30/2001CN1296960A Polypeptide-human CCR4 related protein 31 and polynucleotide for coding said polypeptide